CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) developed for controlled laboratory investigations. It was designed by modifying the native GHRH(1\u201329) peptide sequence, incorporating a drug affinity complex moiety that allows reversible binding to serum albumin. This structural adaptation prolongs the presence of the peptide in circulation within experimental models, offering researchers a stable tool to study pulsatile growth hormone secretion over extended periods. Investigators in endocrinology and metabolic research employ CJC-1295 to examine the GHRH receptor signaling cascade, downstream effects on insulin-like growth factor-1 (IGF-1) levels, and the interplay between the somatotropic axis and metabolic homeostasis. All descriptions of CJC-1295 provided here refer exclusively to its application in scientific studies. The product is strictly for laboratory research use and is not intended for human or veterinary purposes.<\/p>\n
CJC-1295 is a 30\u2011amino acid peptide chain based on the first 29 residues of endogenous GHRH, with an additional cysteine residue at the C\u2011terminus. This cysteine enables conjugation to a maleimide\u2011functionalized reactive group that selectively binds cysteine\u201134 of serum albumin. Once bound, the peptide\u2011albumin complex resists rapid proteolytic degradation and renal clearance, yielding a functional half\u2011life measured in days rather than minutes in animal models. In research systems, CJC-1295 acts as a GHRH receptor agonist, binding to the pituitary somatotroph GHRH receptor and stimulating adenylate cyclase activity, which leads to increased synthesis and secretion of growth hormone. Experimental protocols frequently use CJC-1295 in cell\u2011based assays, tissue explants, and animal models to dissect the regulatory mechanisms of the growth hormone\/IGF\u20111 axis, evaluate receptor desensitization patterns, and explore the relationship between growth hormone pulses and metabolic parameters. Owing to its extended action profile, it is a valuable tool for studies requiring sustained receptor activation without the need for continuous infusion.<\/p>\n
A Certificate of Analysis (COA) is a foundational document that accompanies every batch of a research peptide, providing objective, third\u2011party\u2011verified data on the product\u2019s identity, purity, and physicochemical properties. For investigations where reproducibility is critical, the COA serves as a quality benchmark, confirming that the peptide meets predefined specifications. The document typically reports the net peptide content, enabling accurate molar calculations when preparing stock solutions. It also includes results from orthogonal analytical techniques, most commonly reversed\u2011phase high\u2011performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (MS). HPLC quantifies the relative purity, usually expressed as percent area under the curve at a specific wavelength, while MS confirms the exact molecular mass within accepted tolerance limits. Additional parameters, such as solubility observations, residual counter\u2011ion content (e.g., trifluoroacetate), and water content determined by Karl Fischer titration, may be present depending on the supplier\u2019s quality panel. Without a COA, researchers risk working with degraded or misidentified material, which can compromise data integrity, waste resources, and undermine the validity of peer\u2011reviewed publications. For laboratories operating under good laboratory practice (GLP) or preparing material for pre\u2011clinical study reports, a detailed COA is an essential part of the traceability chain.<\/p>\n
When sourcing CJC\u20111295 for laboratory experiments, the presence and quality of the COA should be a primary selection criterion. A reputable CJC-1295 supplier with COA will transparently share batch\u2011specific analytical data before or at the time of shipment, allowing the end user to assess suitability for the intended study. Institutions may wish to evaluate the supplier\u2019s approach to quality management by examining the scope of testing, the instrumentation used, and whether the COA is generated by an independent analytical unit rather than solely by the synthesis team. The documentation should clearly state the catalog number, lot or batch number, date of analysis, and storage recommendations. Researchers are encouraged to contact the supplier\u2019s technical support team with questions about peak integration methods, column specifications, or MS ionization modes; a technically adept supplier will respond with precise detail.<\/p>\n
A robust quality assurance program for CJC\u20111295 begins with solid\u2011phase peptide synthesis using Fmoc chemistry, followed by rigorous purification steps, typically preparative HPLC, to isolate the target molecule from truncated sequences and deletion by\u2011products. The final lyophilized peptide should be characterized by analytical HPLC demonstrating a purity level of \u226598%, with the chromatogram showing a single predominant peak. Mass spectrometry data should confirm the monoisotopic mass within \u00b11 Da of the theoretical value (for CJC\u20111295 with an albumin\u2011binding conjugate, the expected mass depends on the exact linker chemistry; a fully conjugated form has a distinct mass that should be explicitly reported). Additional tests may include peptide content analysis via amino acid analysis or UV spectrophotometry, counter\u2011ion quantification, and endotoxin determination if required for cell culture work. Suppliers adhering to these standards often perform stability\u2011indicating studies under recommended storage conditions and can provide data on reconstitution behavior. Such thorough characterization supports consistent batch\u2011to\u2011batch performance and is especially critical for longitudinal studies where multiple batches may be used across time points.<\/p>\n
A complete COA for CJC\u20111295 should go beyond purity and mass identity. It should include the percent purity by HPLC and the retention time, the molecular ion peaks observed by MS (with the calculated and observed masses), and the overall net peptide content, which directly affects the preparation of accurate concentration series. Information on storage\u2014such as recommended temperature, protection from light, and anticipated stability after reconstitution in sterile buffers\u2014is an indicator of the supplier\u2019s familiarity with the peptide\u2019s handling characteristics. Transparency in documentation also means traceability: the COA typically references the synthesis workflow, purification steps, and the analytical laboratory that performed the release testing. Suppliers willing to disclose the column chemistry and gradient conditions used during HPLC analysis allow researchers to replicate purity checks in their own laboratories if desired. Such openness reduces the risk of receiving counterfeit or mislabeled material and supports the integrity of research data. When evaluating a CJC-1295 supplier with COA, note whether the document is signed and dated by a quality assurance officer and whether it clearly links to the product\u2019s physical label. This level of detail reflects a commitment to scientific rigor and builds confidence among academic and industrial buyers alike.<\/p>\n
Verifying the authenticity of a COA is a straightforward process that protects the quality of research. Begin by checking that the lot number on the COA matches the lot number printed on the peptide vial label and any accompanying packaging. Examine the documentation for official letterhead, date of issue, and a signature or electronic approval from the quality department. The analytical data should be internally consistent; for example, the mass spectrum should show peaks corresponding to the expected molecular ion, and the HPLC chromatogram should integrate to the stated purity percentage without unexplained shoulders or fronting. Researchers can cross\u2011reference the reported molecular weight with published values for the specific CJC\u20111295 variant they ordered. If any discrepancy arises, contacting the supplier is the next step. A reliable supplier will be able to explain the analytical conditions, provide raw data files upon request, or arrange re\u2011testing if there is reasonable doubt. In collaborative multi\u2011site studies, it is prudent to share COAs among laboratories so that all participants work with verified material, thereby enhancing the robustness of comparative data.<\/p>\n
Our organization focuses on the synthesis and supply of research\u2011grade peptides, including CJC\u20111295, under tightly controlled manufacturing conditions that meet the demands of academic laboratories, pharmaceutical research teams, and global distributors. Every batch of CJC\u20111295 is produced using optimized solid\u2011phase protocols, purified to high homogeneity, and lyophilized in an inert atmosphere to preserve molecular integrity. Before release, each batch undergoes independent analytical evaluation at a partner laboratory that employs calibrated HPLC systems and high\u2011resolution mass spectrometers. The resulting COA is a comprehensive document that reports purity (routinely exceeding 98%), mass identity confirmation, and net peptide content. We understand that timelines in research can be critical; therefore, we maintain sufficient stock levels and offer reliable worldwide shipping with appropriate cold\u2011chain packaging when needed. Our technical staff includes peptide chemists and analytical specialists who can discuss method validation, stability data, and handling recommendations. By choosing our CJC\u20111295 with COA, research institutions gain access to a well\u2011characterized reagent that supports reproducible experimental outcomes and simplifies compliance with internal quality guidelines.<\/p>\n
CJC\u20111295 is available in multiple pack sizes, ranging from milligram quantities suitable for pilot studies to gram\u2011scale batches for large\u2011scale screening programs. Bulk orders and custom synthesis requests are accommodated through a dedicated project management team that can tailor synthesis scales, packaging formats, and analytical deliverables to specific project needs. All shipments include the Certificate of Analysis, a safety data sheet, and documentation required for customs clearance. Distributors benefit from direct access to batch\u2011level data, consistent packaging with tamper\u2011evident seals, and support for re\u2011labeling where local regulations require it. To request a quotation, discuss a custom synthesis, or inquire about our quality systems, please contact our sales team through the official channels listed on our website.<\/p>\n
Solo para uso en investigaci\u00f3n:<\/strong> All products described are intended solely for in vitro laboratory experimentation and scientific research. They are not for use in humans or animals in a diagnostic, therapeutic, or clinical context. Purchasers must be qualified professionals acting within an appropriate institutional framework, and they bear responsibility for ensuring compliance with all applicable laws and regulations governing the procurement and use of research chemicals.<\/p>\n Solo para uso en investigaci\u00f3n. No apto para uso humano ni veterinario.<\/em><\/p>","protected":false},"excerpt":{"rendered":" Introduction to CJC-1295 in Research CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) developed for controlled laboratory investigations. It was designed by modifying the native GHRH(1\u201329) peptide sequence, incorporating a drug affinity complex moiety that allows reversible binding to serum albumin. This structural adaptation prolongs the presence of the peptide in circulation within […]<\/p>\n","protected":false},"author":1,"featured_media":1818,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"news_category":[],"class_list":["post-1817","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"\n